Pregnancy in a patient with metastatic functioning midgut neuroendocrine tumor receiving lanreotide after peptide receptor radionuclide therapy.

Silva BTD, Maia A, Pereira MT, Santos S, Garrido S, Vilaverde J, Moreira MS, Pinto C, Santos AP, Dores J

Open source

DOI
10.20945/2359-4292-2026-0102
Published
2026 Sep 10
Container
Archives of endocrinology and metabolism
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.20945/2359-4292-2026-0102,
  title = {Pregnancy in a patient with metastatic functioning midgut neuroendocrine tumor receiving lanreotide after peptide receptor radionuclide therapy.},
  author = {Silva BTD and Maia A and Pereira MT and Santos S and Garrido S and Vilaverde J and Moreira MS and Pinto C and Santos AP and Dores J},
  year = {2026},
  journal = {Archives of endocrinology and metabolism},
  doi = {10.20945/2359-4292-2026-0102},
  url = {https://doi.org/10.20945/2359-4292-2026-0102}
}

RIS

TY  - JOUR
TI  - Pregnancy in a patient with metastatic functioning midgut neuroendocrine tumor receiving lanreotide after peptide receptor radionuclide therapy.
AU  - Silva BTD
AU  - Maia A
AU  - Pereira MT
AU  - Santos S
AU  - Garrido S
AU  - Vilaverde J
AU  - Moreira MS
AU  - Pinto C
AU  - Santos AP
AU  - Dores J
PY  - 2026
JO  - Archives of endocrinology and metabolism
DO  - 10.20945/2359-4292-2026-0102
UR  - https://doi.org/10.20945/2359-4292-2026-0102
ER  - 

APA

BTD, S., A, M., MT, P., S, S., S, G., J, V., MS, M., C, P., AP, S., & J, D. (2026). Pregnancy in a patient with metastatic functioning midgut neuroendocrine tumor receiving lanreotide after peptide receptor radionuclide therapy.. Archives of endocrinology and metabolism. https://doi.org/10.20945/2359-4292-2026-0102

Source records